Nuvectis Pharma, Inc.

NASDAQ:NVCT

Biotechnology

Healthcare
$19.84 +3.06%

+$0.39 today

Market cap
$682.28M
Beta
-0.07
P/E (TTM)
-11.2
EPS (TTM)
-$1.16
52W Low $5.55High $13.51

Volume 0.16M

Average 0.08M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$16.01M

FY 2025 · Annual

Investing Cash Flow

$0.00

FY 2025 · Annual

Financing Cash Flow

$29.11M

FY 2025 · Annual

+149.8% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(12.89M)(19.09M)(22.26M)(19M)(26.44M)
Depreciation & Amortization00000
Deferred Income Tax00000
Stock-Based Compensation1.89M1.71M4.71M4.86M1.35M
Change in Working Capital1.49M3.82M1.74M1.9M4.4M
Accounts Receivables00000
Inventory00000
Accounts Payables01.85M(139K)(273K)3.78M
Other Working Capital1.49M1.97M1.88M2.17M625K
Other Non-Cash Items00(139K)04.68M
Operating Cash Flow(9.5M)(13.56M)(15.95M)(12.25M)(16.01M)
Capital Expenditures00000
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow00000
Debt Repayment00000
Common Stock Issued15.25M31.88M5.29M12.04M29.11M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities0(4.07M)9.8M(382K)0
Financing Cash Flow15.25M27.81M15.09M11.65M29.11M
Effect of Forex Changes00000
Net Change in Cash5.74M14.25M(867K)(593K)13.1M
Free Cash Flow(9.5M)(13.56M)(15.95M)(12.25M)(16.01M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$26.4M
+ D&A$0
+ Stock-Based Comp$1.4M
+ Deferred Tax$0
+ Working Capital$4.4M
+ Other Non-Cash$4.7M
= Operating Cash Flow-$16.0M
- Capex$0
= Free Cash Flow-$16.0M

Analysis

FY2025 free cash flow is -$16.0M. FCF conversion is 60.5% of net income. Operating cash flow was -$16.0M, with capex of $0. The largest bridge item is Other Non-Cash at $4.7M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
EFFECTEFFECT filingAug 28, 2026
S-3S-3 filingAug 21, 2026
8-KCurrent reportAug 21, 2026

Does NVCT generate free cash flow?

Nuvectis Pharma, Inc. (NVCT) generated -$16.01M of free cash flow in fiscal 2025.

How much operating cash flow does NVCT produce?

Operating cash flow was -$16.01M, before capital expenditures of $0.00.